For PMDD, Does Symptom-Onset Dosing of an SSRI Work?
Symptom-onset dosing with a serotonin reuptake inhibitor for PMDD may have a greater impact on anger/irritability and relationship functioning than other symptoms.
PMDD and Serotonin Reuptake Inhibitors: Does Symptom-Onset Dosing Work?
Multiple studies support the efficacy of serotonin reuptake inhibitors (SRIs) for the treatment of premenstrual dysphoric disorder (PMDD). Â In the initial studies, treatment was administered daily throughout the entire menstrual cycle. Â Researchers observed that for [...]
SSRI Use Associated with Reduced Intention to Breastfeed
Given the potential health benefits of breastfeeding on both mother and baby, the U.S. Public Health Service for Healthy People 2010 set a goal to have 75% of mothers breastfeed in the early postpartum period and 50% of mothers to continue breastfeeding to 6 months by the year 2010 (US Dept of Health and Human Services 2000). Groups of women who are less likely to breastfeed have been targeted in this effort.